Genetic engineering tools targeting TP53 and TP53-deficient cell lines are among the most fundamental experiment materials useful for various cancer studies, particularly for studying the pathological functions of unidentified oncogenes in canine cancers and developing therapeutics. The gene discussed is TP53; the disease is cancer.